HK Stock Market Move | ADD NEW ENERGY (02623) rose nearly 15% again. The company acquired shares of an Australian gold mining company, entering the gold mining sector.
China Datang Corporation Renewable Power (02623) has increased by nearly 15%, as of the time of reporting, it has increased by 11.93% to HKD 5.32, with a turnover of HKD 21.78 million.
ADD NEW ENERGY (02623) rose by nearly 15%, rising 11.93% to HKD 5.32 as of the time of writing, with a turnover of HKD 21.7835 million.
On the news front, ADD NEW ENERGY announced a strategic investment of AUD 39.5 million in Horizon Minerals. Following the completion of the investment, the company will collectively hold approximately 9.95% of the issued share capital of the target company. This also means that the company will officially enter the promising field of gold mining from its original core business of titanium iron ore.
Public information shows that Horizon Minerals is a medium-sized gold producer in Australia. As of February 2026, the estimated mineral resource owned by the company is 34.32 million tons, with an average gold content of 1.7 grams per ton, totaling approximately 1.88 million ounces of gold. Supported by its key assets in Boorara and Burbanks in Western Australia, the company has superior resource endowment and considerable development potential.
Related Articles

Cinda: The long Spring Festival holiday stimulates travel, with scenic spots and inbound tourism performing well.

HK Stock Market Move | DONGYUE GROUP (00189) rose nearly 6%, institutions are optimistic that the prosperity of mainstream refrigerants will continue.

HK Stock Market Move | CSTONE PHARMA-B(02616) rose over 6% again, up over 25% within the month. The British officially approved the phase III clinical trial of sugrelma monoclonal antibodies for NSCLC.
Cinda: The long Spring Festival holiday stimulates travel, with scenic spots and inbound tourism performing well.

HK Stock Market Move | DONGYUE GROUP (00189) rose nearly 6%, institutions are optimistic that the prosperity of mainstream refrigerants will continue.

HK Stock Market Move | CSTONE PHARMA-B(02616) rose over 6% again, up over 25% within the month. The British officially approved the phase III clinical trial of sugrelma monoclonal antibodies for NSCLC.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


